Skip to main contentAI and Advanced
/
ARTEMISMED · NSEBSE SENSEX74,314.59-0.03%BSE |
NIFTY 5023,270.6+0.23%NSE |
NIFTY BANK56,055.75-0.42%NSE |
NIFTY IT29,155.6+0.23%NSE |
NIFTY AUTO27,159.15+0.99%NSE |
NIFTY FMCG45,572.7+0.03%NSE |
NIFTY PHARMA26,579.25+1.66%NSE |
NIFTY 50022,654.65+0.54%NSE |
AR
NSE · Equity shares · Healthcare Facilities-7.35 · -2.22%
Artemis Medicare Services ARTEMISMED
NSE:INR 323.2
BSE:INR 325.6
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for ARTEMISMED
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 330.55
Day rangeINR 306.6 — INR 333.7
52-week rangeINR 202.85 — INR 362
Volume5.34 L
Market cap4,867.17
P/E36.86
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,081.24
Net Income (INR Cr)103.62
Rev Growth (5 Year %)21.5
EPS Growth (5 Year %)68
P/E Ratio36.86
EPS6.64
Research path: Interpret Artemis Medicare Services's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
ARTEMISMEDArtemis Medicare Services1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,428.65 | 1,357.41 | 971.51 |
| Accumulated Depreciation Total | -222.48 | -185.35 | -140.94 |
| Cash Equivalents | 12.65 | 25.55 | 4.97 |
| Other Liabilities Total | 14.76 | 12.85 | 10.57 |
| Accrued Expenses | 0.57 | 8.48 | 0.88 |
| Long Term Debt | 189.95 | 209.48 | 227.72 |
| Common Stock Total | 15.83 | 13.76 | 13.59 |
| Other Equity Total | -3.28 | 317.94 | -2.07 |
| Other Current Assets Total | 5.98 | 5.67 | 0.89 |
| Total Assets | 1,428.65 | 1,357.41 | 971.51 |
| Current Portof LT Debt/Capital Leases | 40.69 | 41.16 | 34 |
| Additional Paid-In Capital | 342.99 | 11.17 | 7.44 |
| Cash | 20.76 | 16.04 | 9.64 |
| Total Equity | 934.71 | 837.68 | 448.35 |
| Long Term Investments | 66.87 | 5.63 | 4.04 |
| Retained Earnings(Accumulated Deficit) | 510.24 | 426.31 | 361.41 |
| Total Common Shares Outstanding | 15.83 | 13.76 | 13.59 |
| Property/Plant/Equipment Total-Gross | 1,001.53 | 918.78 | 845.06 |
| Tangible Book Valueper Share Common Eq | 55.64 | 57.12 | 29.42 |
| Goodwill Net | 41.62 | 41.62 | 41.62 |
| Total Liabilities | 493.94 | 519.73 | 523.16 |
| Total Debt | 261.56 | 290.28 | 320.26 |
| Short Term Investments | 172.29 | 353.63 | 53.61 |
| Cashand Short Term Investments | 205.7 | 395.21 | 68.22 |
| Total Receivables Net | 141.75 | 124.25 | 96.85 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Deferred Income Tax | 41.54 | 35.76 | 35.34 |
| Accounts Receivable-Trade Net | 136 | 122.6 | 94.83 |
| Property/Plant/Equipment Total-Net | 779.05 | 733.43 | 704.11 |
| Minority Interest | 5.97 | 5.88 | 6.33 |
| Total Current Liabilities | 210.81 | 216.13 | 184.65 |
| Total Inventory | 13.42 | 9.98 | 10.08 |
| Accounts Payable | 98.46 | 101.12 | 94.52 |
| Other Currentliabilities Total | 71.09 | 65.36 | 55.26 |
| Total Long Term Debt | 220.87 | 249.12 | 286.26 |
| Intangibles Net | 12.28 | 10.05 | 6.99 |
| Other Long Term Assets Total | 150.74 | 25.84 | 29.18 |
| Note Receivable-Long Term | 11.25 | 5.72 | 5.48 |
| Unrealized Gain(Loss) | 68.93 | 68.49 | 67.98 |
| Total Current Assets | 366.85 | 535.11 | 180.1 |
| Capital Lease Obligations | 30.92 | 39.64 | 58.55 |
| Prepaid Expenses | Not available | Not available | 4.05 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.36
Price to Sale Ratio4.50
Growth
Debt 5Yr CAGR %12.26
Margins
Operating Margin 12m13.52
Operating Margin 5y Avg10.71
Net Profit Margin 12m10.23
Net Profit Margin 5y7.27
Yield
Dividend Yield %0.14
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk37.47
Analyst consensus
ConsensusStrong Buy
Consensus score1.67
Analyst opinions3
Strong Sell count0
Sell count0
Hold count0
Buy count2
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 58.39%
- FII
- 12.28%
- MF
- 1.30%
- Other
- 28.03%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
THE BOARD OF ARTEMIS MEDICARE SERVICES HAS APPROVED SEEKING SHAREHOLDER APPROVAL - ICICI DirectMarket news · 5 Jun 2026, 9:30 am
THE BOARD OF ARTEMIS MEDICARE SERVICES HAS APPROVED SEEKING SHAREHOLDER APPROVAL ICICI Direct
Artemis Medicare to Raise Rs 700 Crore Via Equity Issuance - WhalesbookMarket news · 4 Jun 2026, 7:06 pm
Artemis Medicare to Raise Rs 700 Crore Via Equity Issuance Whalesbook
7 Stocks in Focus After Announcing Fundraising Worth Over ₹3,500 Cr - Trade BrainsMarket news · 4 Jun 2026, 2:16 pm
7 Stocks in Focus After Announcing Fundraising Worth Over ₹3,500 Cr Trade Brains
Artemis Medicare Services Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets MojoMarket news · 4 Jun 2026, 8:05 am
Artemis Medicare Services Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Golden Cross Forms in Artemis Medicare Services Ltd — On a Day the Stock Fell 1.25%. What the Mixed Signals Mean - Markets MojoMarket news · 3 Jun 2026, 6:01 pm
Golden Cross Forms in Artemis Medicare Services Ltd — On a Day the Stock Fell 1.25%. What the Mixed Signals Mean Markets Mojo
ARTEMIS MEDICARE SERVICES WILL HOLD A BOARD MEETING ON JUNE 4, 2026 - ICICI DirectMarket news · 3 Jun 2026, 9:32 am
ARTEMIS MEDICARE SERVICES WILL HOLD A BOARD MEETING ON JUNE 4, 2026 ICICI Direct
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingAGM
- annual General MeetingPOM
- dividendRs.0.4500 per share(45%)Final Dividend
- board MeetingsTo consider Other business matters.
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results & Others
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Artemis Medicare Services
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (hematology), bones, muscles and joints (orthopedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and cardiology, infectious diseases, sleep apnea, kidneys stone treatment and failure (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynecology, psychiatry, arthritis and joint disease, surgery, and urology. It also offers treatment for irregular periods, vertigo, finger joint treatment, and piles. The Company's subsidiary includes Artemis Cardiac Care Private Limited.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- ARTEMISMED
- BSE Code
- 542919
Questions
Stock FAQ
What is the symbol and ISIN of Artemis Medicare Services?
Artemis Medicare Services has the symbol ARTEMISMED and ISIN - INE025R01021.
What is the current price of Artemis Medicare Services?
Artemis Medicare Services is currently trading at INR 323.20.
What are the year high and year low of Artemis Medicare Services?
Artemis Medicare Services has a year high of INR 362.00 and a year low of INR 202.85.
What is the market capitalization of Artemis Medicare Services?
Artemis Medicare Services has a market capitalization of INR 4,867.17 crore.
What is the P/E ratio of Artemis Medicare Services?
Artemis Medicare Services has a P/E ratio of 36.86.
What is the dividend yield of Artemis Medicare Services?
Artemis Medicare Services has a dividend yield of 0.14%.
How is the financial performance of Artemis Medicare Services based on revenue, net income, and EPS?
Artemis Medicare Services has revenue of INR 1,081.24 crore, net income of INR 103.62 crore, and EPS of INR 7.32.
What is the book value of Artemis Medicare Services?
Artemis Medicare Services has a book value of NA.
What is the debt-to-equity ratio of Artemis Medicare Services?
Artemis Medicare Services has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Artemis Medicare Services?
Artemis Medicare Services has a price-to-book ratio of NA and a price-to-sales ratio of 4.50.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.